A STUDY TO DETERMINE CO‐RELATION BETWEEN DISEASE BURDEN, NUMBER OF CLINICAL TRIALS DONE AND SUCCESS RATES FOR GERMANY AND INDIA.

Journal Title: Journal of Evidence Based Medicine and Healthcare - Year 2014, Vol 1, Issue 17

Abstract

The drugs we use to treat any condition – from an innocuous cough to a lifethreatening cancer – are the outcome of painstaking human clinical trials. These trials are the only way to credibly determine the safety and efficacy of drugs. In recent years there has been a clear shift in clinical trial sites from core developed countries like USA, European countries to developing countries like India, China, South American countries. This shift is related to challenges and opportunities like costs of trials, recruitment issues, and regulatory challenges in developed vs. developing countries. Developing countries and developed countries have their unique disease burden patterns based on various parameters like but not limited to age, health care facilities, health insurance, sanitary conditions, environmental issues, education, nutrition and GDP. Previous studies have reported that many of the important global diseases are not much explored in clinical trials and many published clinical trials have very less international health relevance. This study was aimed at finding the correlation between disease burdens, number of clinical trials done and trial success rates. We compared 2005-2010 Global Burden of Disease data for Germany, India and number of clinical trials from clinicaltrials.gov database done in the same period. Our findings indicated that there was a good correlation between the disease burden and clinical trials for Germany in 2005 and 2010. For India in 2005 there was a moderate positive correlation, 2010 data showed the improvement in India in terms of match between disease burden and clinical Trials. But careful observation of the data shows still a need for more trials on Communicable, maternal, neonatal and nutritional disorders.

Authors and Affiliations

Dnyanesh Limaye, Gerhard Fortwengel, Vaidehi Limaye

Keywords

Related Articles

CT EVALUATION IS MUST FOR PROGNOSIS PREDICTION IN ACUTE PANCREATITIS; RESULTS OF A TWO YEAR PROSPECTIVE STUDY

BACKGROUND This study emphasizes the importance of computed tomography (CT) imaging in acute pancreatitis to grade clinical severity and predict outcome. The clinical and radiological findings in acute pancreatitis were...

PARAGANGLIOMA: A CASE REPORT

INTRODUCTION Paragangliomas are relatively rare endocrine tumours that arise from paraganglionic tissue, a widely dispersed collection of specialized neural crest cells. In the absence of histological diagnosis and sympt...

SURGICAL MANAGEMENT OF CHRONIC ACHILLES TENDON RUPTURES WITH BOSWORTH TECHNIQUE- A PROSPECTIVE STUDY

BACKGROUND The Achilles tendon is the strongest tendon in the human body. Retraction and atrophy of the tendon ends, scar tissue between the tendon ends makes primary repair of the chronic Achilles tendon tear difficult....

ENDOMETRIAL HYPERPLASIA – WHAT IS NEW?

The diagnosis and classification of endometrial hyperplasia is still one of the rare areas in histopathology that is still purely based on morphology without the use of ancillary techniques. The two popular systems used...

STUDY ON VISUAL OUTCOME FOLLOWING TORIC IOL IMPLANTATION IN CATARACT PATIENTS WITH ASTIGMATISM

BACKGROUND The aim of this study was to determine the efficacy of toric IOL placement in astigmatic patients with immature cataract. MATERIALS AND METHODS This prospective study included 20 eyes of 20 patients with a vis...

Download PDF file
  • EP ID EP227869
  • DOI 10.18410/jebmh/2014/315
  • Views 68
  • Downloads 0

How To Cite

Dnyanesh Limaye, Gerhard Fortwengel, Vaidehi Limaye (2014). A STUDY TO DETERMINE CO‐RELATION BETWEEN DISEASE BURDEN, NUMBER OF CLINICAL TRIALS DONE AND SUCCESS RATES FOR GERMANY AND INDIA.. Journal of Evidence Based Medicine and Healthcare, 1(17), 2186-2196. https://europub.co.uk./articles/-A-227869